
Susanna Moore
Examiner (ID: 4754)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624 |
| Total Applications | 1838 |
| Issued Applications | 1086 |
| Pending Applications | 196 |
| Abandoned Applications | 608 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11038799
[patent_doc_number] => 20160235754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/140874
[patent_app_country] => US
[patent_app_date] => 2016-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61766
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15140874
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/140874 | HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS | Apr 27, 2016 | Abandoned |
Array
(
[id] => 11400341
[patent_doc_number] => 20170020879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'PYRAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/139361
[patent_app_country] => US
[patent_app_date] => 2016-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22293
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15139361
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/139361 | Pyrazolopyridyl compounds as aldosterone synthase inhibitors | Apr 26, 2016 | Issued |
Array
(
[id] => 11113527
[patent_doc_number] => 20160310497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/135121
[patent_app_country] => US
[patent_app_date] => 2016-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 80936
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15135121
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/135121 | Purine derivatives useful as HSP90 inhibitors | Apr 20, 2016 | Issued |
Array
(
[id] => 11032911
[patent_doc_number] => 20160229868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/099815
[patent_app_country] => US
[patent_app_date] => 2016-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 38626
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15099815
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/099815 | NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY | Apr 14, 2016 | Abandoned |
Array
(
[id] => 12603108
[patent_doc_number] => 20180092866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => SUBSTITUTED N-([1,1'-BIPHENYL]-3-YL)-[1,1'-BIPHENYL]-3-CARBOXAMIDE ANALOGS AS INHIBITORS FOR BETA-CATENIN/B-CELL LYMPHOMA 9 INTERACTIONS
[patent_app_type] => utility
[patent_app_number] => 15/566568
[patent_app_country] => US
[patent_app_date] => 2016-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 441
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15566568
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/566568 | SUBSTITUTED N-([1,1'-BIPHENYL]-3-YL)-[1,1'-BIPHENYL]-3-CARBOXAMIDE ANALOGS AS INHIBITORS FOR BETA-CATENIN/B-CELL LYMPHOMA 9 INTERACTIONS | Apr 13, 2016 | Abandoned |
Array
(
[id] => 11090628
[patent_doc_number] => 20160287596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'Benzoxazole Kinase Inhibitors and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 15/092833
[patent_app_country] => US
[patent_app_date] => 2016-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 139279
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15092833
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/092833 | Benzoxazole Kinase Inhibitors and Methods of Use | Apr 6, 2016 | Abandoned |
Array
(
[id] => 12239852
[patent_doc_number] => 20180072715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'IMIDAZOLONYLQUINOLINES AND THE USE THEREOF AS ATM KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/563680
[patent_app_country] => US
[patent_app_date] => 2016-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40023
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563680
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/563680 | Imidazolonylquinolines and the use thereof as ATM kinase inhibitors | Mar 30, 2016 | Issued |
Array
(
[id] => 10997393
[patent_doc_number] => 20160194338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'SUBSTITUTED TETRAHYDROCARBAZOLE AND CARBAZOLES CARBOXAMIDE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/067915
[patent_app_country] => US
[patent_app_date] => 2016-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 70283
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15067915
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/067915 | SUBSTITUTED TETRAHYDROCARBAZOLE AND CARBAZOLES CARBOXAMIDE COMPOUNDS | Mar 10, 2016 | Abandoned |
Array
(
[id] => 12184011
[patent_doc_number] => 20180042948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'BORON-DIPYRRIN COMPLEX AND MEDICAMENT CONTAINING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/555721
[patent_app_country] => US
[patent_app_date] => 2016-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11441
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555721
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/555721 | Boron-dipyrrin complex and medicament containing the same | Mar 3, 2016 | Issued |
Array
(
[id] => 10988856
[patent_doc_number] => 20160185800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/059962
[patent_app_country] => US
[patent_app_date] => 2016-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 70150
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15059962
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/059962 | Certain chemical entities, compositions and methods | Mar 2, 2016 | Issued |
Array
(
[id] => 11872424
[patent_doc_number] => 09744172
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'Pyrazolopyrimidine compounds for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 15/055756
[patent_app_country] => US
[patent_app_date] => 2016-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35286
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15055756
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/055756 | Pyrazolopyrimidine compounds for the treatment of cancer | Feb 28, 2016 | Issued |
Array
(
[id] => 12680665
[patent_doc_number] => 20180118721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => PYRIMIDINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 15/550383
[patent_app_country] => US
[patent_app_date] => 2016-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550383
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550383 | PYRIMIDINE DERIVATIVES | Feb 11, 2016 | Abandoned |
Array
(
[id] => 15355499
[patent_doc_number] => 10526350
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Process for the preparation of baricitinib and an intermediate thereof
[patent_app_type] => utility
[patent_app_number] => 15/548116
[patent_app_country] => US
[patent_app_date] => 2016-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1844
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548116
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/548116 | Process for the preparation of baricitinib and an intermediate thereof | Feb 1, 2016 | Issued |
Array
(
[id] => 11038798
[patent_doc_number] => 20160235755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK'
[patent_app_type] => utility
[patent_app_number] => 15/010619
[patent_app_country] => US
[patent_app_date] => 2016-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20824
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15010619
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/010619 | Heterocyclic compounds for the inhibition of PASK | Jan 28, 2016 | Issued |
Array
(
[id] => 12118705
[patent_doc_number] => 20180002292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'PROCESS FOR THE PRODUCTION OF CONDENSED IMIDAZOLO DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 15/546707
[patent_app_country] => US
[patent_app_date] => 2016-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7547
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15546707
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/546707 | Process for the production of condensed imidazolo derivatives | Jan 27, 2016 | Issued |
Array
(
[id] => 13717135
[patent_doc_number] => 20170369522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => 3.ALPHA.-ETHYNYL, 3.BETA.-HYDROXY-5.ALPHA.-PREGNAN-20-OXIME FOR USE IN THE TREATMENT OF CNS DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/542800
[patent_app_country] => US
[patent_app_date] => 2016-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542800
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/542800 | 3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treatment of CNS disorders | Jan 10, 2016 | Issued |
Array
(
[id] => 13702541
[patent_doc_number] => 20170362225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => BICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/541875
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541875
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/541875 | Bicyclic compounds, compositions and medicinal applications thereof | Jan 7, 2016 | Issued |
Array
(
[id] => 10997373
[patent_doc_number] => 20160194319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'PYRIDOPYRIMIDINE BASED DERIVATIVES AS POTENTIAL PHOSPHODIESTERASE 3 (PDE3) INHIBITORS AND A PROCESS FOR THE PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/988830
[patent_app_country] => US
[patent_app_date] => 2016-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8250
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14988830
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/988830 | Pyridopyrimidine based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof | Jan 5, 2016 | Issued |
Array
(
[id] => 12979489
[patent_doc_number] => 20170342032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => CARBAMATE COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/541799
[patent_app_country] => US
[patent_app_date] => 2016-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541799
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/541799 | Carbamate compound and use thereof | Jan 4, 2016 | Issued |
Array
(
[id] => 14727915
[patent_doc_number] => 10383333
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-20
[patent_title] => Carbamate compound and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/541821
[patent_app_country] => US
[patent_app_date] => 2016-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8748
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541821
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/541821 | Carbamate compound and use thereof | Jan 4, 2016 | Issued |